ZYME Q2 2023 Earnings — Zymeworks Inc. Revenue & Financial Results | Market Cap Arena

ZYMEZymeworks Inc.

$2B

Q2 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$7M+28.7% YoY

Gross Profit

-$32M-462.8% margin

Operating Income

-$54M-772.8% margin

Net Income

-$51M-730.5% margin

EPS (Diluted)

$-0.76

QoQ Revenue Growth

-80.3%

Cash Flow

Operating Cash Flow

-$6M

Free Cash Flow

-$7M

Stock-Based Comp.

$367,000

Balance Sheet

Total Assets

$602M

Total Liabilities

$153M

Stockholders' Equity

$449M

Cash & Equivalents

$142M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$7M	$5M	+28.7%
Gross Profit	-$32M	-$51M	+35.9%
Operating Income	-$54M	-$66M	+17.8%
Net Income	-$51M	-$65M	+20.8%

Revenue Segments

Research Support Payments And Other Service

$538,000100%